Fig. 7.
Comparison of GPIIb-IIIa incorporation into the cytoskeletal cores with platelet aggregation response.
Aggregation response and GPIIb-IIIa incorporation in response to ADP was normalized to 100% in 3 separate treatment groups. The percent maximum aggregation response (■) and percent maximum GPIIb-IIIa incorporation (○) was determined for spontaneous, D3, and D3 then ADP treatments. The data are the mean ± SD (n = 3).